Trial intelligence / Profile preview

Probiotics for Birch Pollen Allergy in Children

NCT00746226Phase 2Completed

Sponsor
Danisco
Start
Mar 2006
Primary completion
Jun 2006
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of lactobacillus acidophilus NCFM, bifidobacterium lactis Bl-04 in seasonal allergic rhinitis (SAR), sponsored by Danisco. Started Mar 2006; status: completed.

02

Drugs

lactobacillus acidophilus NCFMbifidobacterium lactis Bl-04
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00746226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00746226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call